References
- Buttar H. S., Moffatt J. M., Bura C. Transplacental and mammary passage of radioactivity in rats treated vaginally and orally with ‘14C’propranolol. Journal of Toxicology and Environmental Health 1988; 24: 1–18
- Cleaveland C. R., Shand D. G. Effect of route of administration on the relationship between β-adrenergic blockade and plasma propranolol level. Clinical Pharmacology and Therapeutics 1972; 13: 181–185
- Fitzgerald J. D., O'Donnell S. R. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol. British Journal of Pharmacology 1971; 43: 222–235
- Gibaldi M., Perrier D. Route of administration and drug disposition. Drug Metabolism Reviews 1974; 3: 185–199
- Hayes A., Cooper R. G. Studies on the absorption, distribution, and excretion of propranolol in rat, dog, and monkey. Journal of Pharmacology and Experimental Therapeutics 1971; 176: 302–311
- Patel L. G., Warrington S. J., Pearson R. M. Propranolol concentrations in plasma after insertion into vagina. British Medical Journal 1983; 287: 1247–1248
- Paterson J. W., Conolly M. E., Dollery C. T., Hayes A., Cooper R. G. The pharmacodynamics and metabolism of propranolol in man. Pharmacologia Clinica 1970; 2: 127–133
- Pearson R. M., Hong C. Y., Patel L. G., Tuner P., Potts D. M., Wheeler R., Zipper J. Studies on membrane-active vaginal spermicides. Contraceptive Delivery Systems 1984; 5: 303–309
- Qureshi S. A., Buttar H. S. High performance liquid chromatographic determination of propranolol in rat serum. Journal of Chromatography 1988; 431: 465–470
- Routledge P. A., Shand D. G. Clinical pharmacokinetics of propranolol. Clinical Pharmacokinetics 1979; 4: 73–90
- Shand D. G., Rangno R. E. The disposition of propranolol I. Elimination during oral absorption in man. Pharmacology 1972; 7: 159–168
- Shand D. G., Evans G. H., Nies A. S. The almost complete hepatic extraction of propranolol during intravenous administration in the dog. Life Sciences 1971; 10: 1417–1421
- Shand D. G., Rangno R. E., Evans G. H. The disposition of propranolol II. Hepatic elimination in the rat. Pharmacology 1972; 8: 344–352
- Silber B. M., Holford N. H. G., Riegelman S. Dose-dependent elimination of propranolol and its major metabolites in humans. Journal of Pharmaceutical Sciences 1983; 72: 725–732
- Smith R. C., Berge M. Systemic absorption after intravaginal propranolol. Lancet 1985; 1: 112
- Walle T., Gaffney T. E. Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. Journal of Pharmacology and Experimental Therapeutics 1972; 182: 83–92
- Walle T., Morrison J. I., Tindell G. L. Isomeric ring hydroxylated metabolites of propranolol in rat, man and dogs. Research Communications in Chemical Pathology and Pharmacology 1974; 9: 1–9
- Walle T., Fagan T. C., Conradi E. C., Walle U. K., Gaffney T. E. Presystemic and systemic glucuronidation of propranolol. Clinical Pharmacology and Therapeutics 1979; 26: 167–172
- Walle T., Conradi E. C., Walle U. K., Fagan T. C., Gaffney T. E. 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol. Clinical Pharmacology and Therapeutics 1980; 27: 22–31
- Walle T., Walle U. K., Olanoff L. S. Quantitative account of propranolol metabolism in urine of normal man. Drug Metabolism and Disposition 1985; 13: 204–209
- Zipper J., Bruzzone M. E., Angelo S., Munoz V., Wheeler R. G. Effect of topically applied adrenergic blockers on fertility. International Journal of Fertility 1982; 27: 242–245
- Zipper J., Wheeler R. G., Potts D. M., Rivera M. Propranolol as a novel, effective spermicide: preliminary findings. British Medical Journal 1983; 287: 1245–1246